GLYCOMIMETICS INC's ticker is GLYC and the CUSIP is 38000Q102. A total of 59 filers reported holding GLYCOMIMETICS INC in Q3 2017. The put-call ratio across all filers is 137.00 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $3,875,000 | +63.0% | 311,013 | +23.9% | 0.35% | +32.1% |
| Q4 2018 | $2,377,000 | -34.2% | 251,013 | 0.0% | 0.27% | -35.4% |
| Q3 2018 | $3,615,000 | -6.6% | 251,013 | +4.6% | 0.42% | -22.3% |
| Q2 2018 | $3,870,000 | +58.9% | 239,933 | +60.0% | 0.53% | +44.3% |
| Q1 2018 | $2,435,000 | -55.4% | 150,000 | -53.8% | 0.37% | -42.2% |
| Q4 2017 | $5,457,000 | +52.4% | 325,000 | +1.3% | 0.64% | +5.3% |
| Q2 2017 | $3,580,000 | -15.0% | 320,796 | -58.6% | 0.61% | -26.2% |
| Q1 2017 | $4,213,000 | -7.4% | 775,796 | +4.0% | 0.82% | -28.4% |
| Q4 2016 | $4,549,000 | -11.4% | 745,796 | +3.9% | 1.15% | +37.7% |
| Q3 2016 | $5,134,000 | -1.6% | 718,080 | 0.0% | 0.84% | -38.3% |
| Q2 2016 | $5,220,000 | +159.2% | 718,080 | +112.5% | 1.36% | +210.1% |
| Q1 2016 | $2,014,000 | +16.3% | 337,911 | +218.8% | 0.44% | +10.6% |
| Q1 2014 | $1,731,000 | – | 106,000 | – | 0.40% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 7,361,801 | $38,944,000 | 2.95% |
| NEA Management Company, LLC | 9,089,041 | $48,081,000 | 2.27% |
| Camber Capital Management LP | 3,500,000 | $18,515,000 | 0.94% |
| Redmile Group, LLC | 1,343,845 | $7,109,000 | 0.17% |
| CAXTON CORP | 25,748 | $136,000 | 0.13% |
| Alambic Investment Management, L.P. | 15,210 | $80,000 | 0.07% |
| Virtus ETF Advisers LLC | 69,120 | $366,000 | 0.06% |
| OXFORD ASSET MANAGEMENT LLP | 133,008 | $704,000 | 0.02% |
| AXA S.A. | 1,890,492 | $10,002,000 | 0.02% |
| Athanor Capital, LP | 59,572 | $315,000 | 0.01% |